PharmAthene, Inc. (PIP) Short Interest Update
PharmAthene, Inc. (NYSE:PIP) was the recipient of a large increase in short interest during the month of October. As of October 31st, there was short interest totalling 1,745,836 shares, an increase of 3.6% from the October 14th total of 1,685,715 shares. Based on an average daily trading volume, of 102,372 shares, the short-interest ratio is currently 17.1 days. Approximately 2.8% of the shares of the company are sold short.
Separately, TheStreet upgraded shares of PharmAthene from a “sell” rating to a “hold” rating in a research report on Wednesday, August 10th.
PharmAthene (NYSE:PIP) opened at 2.95 on Friday. The company has a 50-day moving average of $2.82 and a 200-day moving average of $2.55. PharmAthene has a 52-week low of $1.38 and a 52-week high of $2.95. The stock has a market capitalization of $196.85 million and a price-to-earnings ratio of 1.67.
Pharmathene, Inc (Pharmathene) is a biodefense company. The Company is focused on the development of medical counter measures against biological and chemical threats. The Company is involved in the development of two next generation anthrax vaccines. The Company’s anthrax vaccines use recombinant protective antigen (rPA) manufacturing processes.
Receive News & Stock Ratings for PharmAthene Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PharmAthene Inc. and related stocks with our FREE daily email newsletter.